1. Dietary Energy Modulation and Autophagy: Exploiting Metabolic Vulnerabilities to Starve Cancer
   Alyssa J. Cozzo et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
2. Antidepressants as Autophagy Modulators for Cancer Therapy
   Leping He et al, 2023, Molecules CrossRef
3. Cell Injury and Necrosis
   J.C. Davila et al, 2018, Comprehensive Toxicology CrossRef
4. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
   Cally J. Ho et al, 2019, Cancers CrossRef
5. Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer
   Zhaoyun Liu et al, 2017, PLOS ONE CrossRef
6. Comparative pharmacokinetic study of PEGylated gemcitabine and gemcitabine in rats by LC-MS/MS coupled with pre-column derivatization and MSALL technique
   Lei Yin et al, 2020, Talanta CrossRef
7. Repurposing autophagy regulators in brain tumors
   Edgar Petrosyan et al, 2022, International Journal of Cancer CrossRef
8. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells
   Xiangxin Kong et al, 2024, Molecular Medicine Reports CrossRef
9. Identification of DHODH as a therapeutic target in small cell lung cancer
   Leanne Li et al, 2019, Science Translational Medicine CrossRef
10. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer
    Fang-Tao Wang et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
11. Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
    Valdenizia R. Silva et al, 2020, Cancers CrossRef
12. Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death
    Hui-Mei Wu et al, 2016, Lung CrossRef
13. Regulation of multidrug resistance by microRNAs in anti-cancer therapy
    Xin An et al, 2017, Acta Pharmaceutica Sinica B CrossRef
14. Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells
    Xiao-Long Huang et al, 2017, Anti-Cancer Drugs CrossRef
15. Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis
    Takashi Ando et al, 2020, Cancers CrossRef
16. Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox
    Adria Hasan et al, 2022, Frontiers in Oncology CrossRef
17. Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
    Chao Wu et al, 2019, Experimental and Therapeutic Medicine CrossRef
18. Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity
    Nahla E. El-Ashmawy et al, 2020, Life Sciences CrossRef
19. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
    Maria Grazia Ferraro et al, 2020, Cells CrossRef
20. A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
    null Santos et al, 2019, Genes CrossRef